未登录

M

Magdalena Kolasa

pharmacology

H指数:14

被引数:602

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A validated FACS-based protocol for the isolation of neuronal and non-neuronal cells from frozen adult brain, suitable for integrated gene and protein analysis

一种基于FACS的验证协议，用于从冷冻成人脑中分离神经元和非神经元细胞，适用于整合基因和蛋白质分析

Pharmacological Reports

IF3.8

2026-04-220

PRE

Differential Regulation of Proteins Related to the Blood–Brain Barrier in Stress-Resilient and Stress-Susceptible Mice

血脑屏障相关蛋白在抗应激和易感应激小鼠中的差异调控

Journal of Neurochemistry

IF4

2025-07-300

PRE

Predictive value of 68[Ga]Ga-DOTA-TATE PET/CT volumetric parameters in assessing treatment response to long-acting somatostatin analogues in patients with well-differentiated neuroendocrine tumours

EJNMMI RESEARCH

IF3

2024-11-130

OAAI

Enhancement of Glutamate Uptake as Novel Antiseizure Approach: Preclinical Proof of Concept

ANNALS OF NEUROLOGY

IF7.7

2024-11-080

OA

Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression (Jul, 10.1007/s00213-024-06644-3, 2024)

PSYCHOPHARMACOLOGY

IF3.3

2024-07-201

OAAI

Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression

PSYCHOPHARMACOLOGY

IF3.3

2024-07-045

OAAI

24-hour urine metanephrine excretion in patients diagnosed with adrenal incidentaloma: impact of commonly used drugs on a clinical decision

POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ

IF4.7

2024-01-022

OA

Preclinical models of treatment-resistant depression: challenges and perspectives

PHARMACOLOGICAL REPORTS

IF3.8

2023-10-267

OAAI

The functional cooperation of 5-HT1Aand mGlu4R in HEK-293 cell line

PHARMACOLOGICAL REPORTS

IF3.8

2020-05-294

OAAI

Serum Level of miR-1 and miR-155 as Potential Biomarkers of Stress-Resilience of NET-KO and SWR/J Mice

IF5.2

2020-04-0911

OAAI

NET-KO mice as a stress-resistant model-miRNAs studies

PHARMACOLOGICAL REPORTS

IF3.8

2019-12-010

PREAI

Behavioral response to imipramine under chronic mild stress corresponds with increase of mRNA encoding somatostatin receptors sst2 and sst4 expression in medial habenular nucleus

NEUROCHEMISTRY INTERNATIONAL

IF4

2018-12-013

PREAI

Regulation of somatostatin receptor 2 in the context of antidepressant treatment response in chronic mild stress in rat

PSYCHOPHARMACOLOGY

IF3.3

2018-04-3012

OAAI

Chronic administration of clozapine increases the level of serotonin 5-HT1A receptor heterodimerisation with 5-HT2A or D2 receptors in the mouse cortex

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2018-03-010

PREAI

Repeated Clozapine Increases the Level of Serotonin 5-HT1AR Heterodimerization with 5-HT2A or Dopamine D2 Receptors in the Mouse Cortex

FRONTIERS IN MOLECULAR NEUROSCIENCE

IF3.8

2018-02-1532

OAAI

Effects of imipramine on cytokines panel in the rats serum during the drug treatment and discontinuation

NEUROCHEMISTRY INTERNATIONAL

IF4

2018-02-013

PREAI

Antidepressants promote formation of heterocomplexes of dopamine D2 and somatostatin subtype 5 receptors in the mouse striatum

BRAIN RESEARCH BULLETIN

IF3.7

2017-10-017

PREAI

Effect of clozapine on ketamine-induced deficits in attentional set shift task in mice

PSYCHOPHARMACOLOGY

IF3.3

2017-04-1225

OAAI

Time-dependent miR-16 serum fluctuations together with reciprocal changes in the expression level of miR-16 in mesocortical circuit contribute to stress resilient phenotype in chronic mild stress - An animal model of depression

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-01-0142

PREAI

Chronic mild stress alters the somatostatin receptors in the rat brain

PSYCHOPHARMACOLOGY

IF3.3

2015-10-1437

OAAI